Avalon Capital Management’s Global X Scientific Beta Europe ETF SCID Stock Holding History

Avalon Capital Management’s Portfolio SCID Stock Details SCID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-53,332	Closed	-$1.51M	–	107
2017 Q3	$1.51M	Buy	+53,332	New	+$1.47M	1.05%	40

Other funds holding SCID

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Avalon Capital Management's SCID Position: Q4 2017 in Review

Avalon Capital Management sold out of Global X Scientific Beta Europe ETF (SCID) in Q4 2017, closing a stake of 53,332 shares — an estimated $1.51M sold.

Avalon Capital Management first reported a position in SCID in Q3 2017 and held it in 1 quarter. The position peaked at $1.51M in Q3 2017. 4 funds tracked by Wall St. Rank hold SCID as of Q4 2017.

Avalon Capital Management reported no remaining Global X Scientific Beta Europe ETF position as of Q4 2017 after selling out during the quarter.
Avalon Capital Management sold 53,332 Global X Scientific Beta Europe ETF shares in Q4 2017, an estimated $1.51M.
Avalon Capital Management first reported a position in Global X Scientific Beta Europe ETF in Q3 2017 and held it in 1 quarter.
Avalon Capital Management's Global X Scientific Beta Europe ETF position peaked at $1.51M in Q3 2017.
4 funds tracked by Wall St. Rank held Global X Scientific Beta Europe ETF as of Q4 2017.

Based on Avalon Capital Management's 13F filing for Q4 2017, filed 26 Jan 2018.